3.180USD0.00%Mkt Cap: 819.46M $P/E: Infinity4d ago
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's …
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap819.46M $
Enterprise Value1.21B $
Revenue (TTM)418.24M $
Gross Profit273.91M $
Net Income (TTM)-22.68M $
Revenue/Share1.887 USD
Last Price3.180 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees294
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS29664W1053
Valuation
P/E (Trailing)Infinity
P/E (Forward)12.35
PEG—
EV/EBITDA15.89
EV/Revenue2.88
P/S1.96
P/B-2.66
EPS (TTM)0.00
EPS (Forward)0.26
52W Range
1.10068% of range4.180
52W High4.180 USD
52W Low1.100 USD
Profitability
Gross Margin67.95%
Oper. Margin-8.22%
EBITDA Margin18.15%
Profit Margin-5.63%
ROE7.51%
ROA-4.87%
Growth
Revenue Growth23.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.09M $
CapEx (TTM)—
FCF Margin-11.88%
FCF Yield-6.07%
Net Debt387.65M $
Net Debt/EBITDA5.11
Balance Sheet
Debt/Equity-0.84
Current Ratio1.53
Quick Ratio0.96
Book Value/Sh-1.1960 USD
Cash/Share0.6070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.200 USD
Upside (mean)+0.6%
Target Range3.160 USD – 3.280 USD
$3.160+0.6% to mean$3.280
# Analysts3
Ownership
Shares Out.257.69M
Float234.89M
Insiders0.90%
Institutions71.54%
Short Interest
Short Ratio1.6d
Short % Float6.87%
Short % Out.6.75%
Shares Short17.40M
Short (prev mo.)18.71M
Technical
SMA 503.147 (+1.0%)
SMA 2003.087 (+3.0%)
Beta1.06
S&P 52W Chg20.25%
Avg Vol (30d)12.06M
Avg Vol (10d)20.98M
Technical Indicators
RSI (14)65.0
MACD0.0308
MACD Signal0.0382
MACD Hist.-0.0074
BB Upper3.187 USD
BB Middle3.162 USD
BB Lower3.137 USD
BB Width1.57%
ATR (14)0.0210 USD
Vol Ratio (20d)0.00x